$CPRX Roth Capital’s Scott Henry Maintains Buy On Catalyst Pharmaceutical Following Firdapse Phase 3 Completion http://www.smarteranalyst.com/2014/08/13/catalyst-pharmaceutical-partners-inc-cprx/